CHK
48
15
EL
30
-3
DE
53
8
ISRG
68
-3
IPG
39
-3
EBAY
47
-2
VRTX
53
-2
RSG
59
2
MMM
52
2
GOOG
67
2
HOG
50
6
ADI
59
-2
BWA
45
-4
UPS
55
-6
MAR
60
7
PCG
80
3
TXN
50
-3
FTI
82
4
SEE
38
-3
MAT
51
-3
CHK
48
15
EL
30
-3
DE
53
8
ISRG
68
-3
IPG
39
-3
EBAY
47
-2
VRTX
53
-2
RSG
59
2
MMM
52
2
GOOG
67
2
HOG
50
6
ADI
59
-2
BWA
45
-4
UPS
55
-6
MAR
60
7
PCG
80
3
TXN
50
-3
FTI
82
4
SEE
38
-3
MAT
51
-3
Financhill
Back

iShares MSCI Europe Financials ETF Vs. Apellis Pharmaceuticals Industry Stock Comparison

Buy
73

EUFN
iShares MSCI Europe Financials ETF

Last Price:
24.57
Seasonality Move:
1.4%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Buy
73
iShares MSCI Europe Financials ETF (EUFN) is a Buy

Is iShares MSCI Europe Financials ETF a Buy, Sell or Hold?

  • The current iShares MSCI Europe Financials ETF [EUFN] share price is $24.57. The Score for EUFN is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
  • EUFN is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

EUFN Stock Price Chart

What is iShares MSCI Europe Financials ETF's stock price today?

  • The iShares MSCI Europe Financials ETF share price today is $24.57
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EUFN is experiencing slight selling pressure.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

EUFN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.32 Buy
Relative Strength Index (14 RSI): 63.67 Buy
Chaikin Money Flow: -16973 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (23.56 - 24.28) Buy
Bollinger Bands (100): (22.53 - 23.99) Buy

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

EUFN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 24.23 Buy
20-day SMA: 24.03 Buy
50-day SMA: 23.34 Buy
200-day SMA: 22.29 Buy
8-day EMA: 24.3 Buy
20-day EMA: 23.97 Buy
50-day EMA: 23.53 Buy
200-day EMA: 22.3 Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

iShares MSCI Europe Financials ETF Earnings Growth & EUFN Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

iShares MSCI Europe Financials ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):